A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Pulmonx Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 20,750 shares of LUNG stock, worth $128,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,750
Previous 19,524 6.28%
Holding current value
$128,650
Previous $123,000 39.84%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.59 - $8.58 $6,853 - $10,519
1,226 Added 6.28%
20,750 $172,000
Q2 2024

Aug 14, 2024

BUY
$5.77 - $9.82 $112,653 - $191,725
19,524 New
19,524 $123,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $231M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.